PubHealth.info® (An Information Portal on Public Health Issues / Topics, Presented in Collaboration with PakMed Biomedical Solutions)

[PubHealth.info Homepage] [Category Homepage] [Disclaimer/Copyrights] [Feedback]


Thank you for your kind visit to PubHealth.info®, an information portal created in technical collaboration with PakMed Biomedical Solutions * * * PubHealth.info® presents hundreds of thousands of informative Web pages on a variety of public health issues / issues * * * An ultimate source of information for teachers, students and research workers who need to find information on various public health issues, like population planning, contraception, HIV AIDS, STDs, maternal and child health, communicable and non-communicable disease, etc. * * * PubHealth.info® regularly updates the repository of these hundreds of thousands of informative Web pages * * * PubHealth.info® is one of the world's largest repositories and information portals with online Web pages on public health issues particularly those pertaining to developing countries!

PubHealth.info® (a subsidiary of PakMed) presents scientific information mainly based on abstracts of articles published on a variety of public health issues/topics, particularly encompassing population planning, disease prevention, maternal and child health, and communicable and non-communicable diseases (like HIV AIDS, malaria, etc) that are affecting a significant portion of population in developing and developed countries. Here you can find abstracts of articles published on a variety of public health topics under category "Contraception (Birth Control) and Family Planning". Contraception (birth control) is a regimen of one or more actions, devices, or medications followed in order to deliberately prevent or reduce the likelihood of a woman becoming pregnant or giving birth. Therefore contraception is the utilization of various and sundry surgical procedures, devices, practices, agents, or drugs with the intention of preventing conception or impregnation (pregnancy). Methods and intentions typically termed birth control may be considered a pivotal ingredient to family planning. Birth control is a controversial political and ethical issue in many cultures and religions, and although it is generally less controversial than abortion specifically.

Here you can find more than 42,000 article titles on "Contraception (Birth Control) and Family Planning" , along with their abstracts and bibliographic information (one of the world's largest collections of article titles on this topic), mentioned in various lists that are sorted/arranged according to the years of publication. You can view the bibliographic details and abstracts of these articles, by clicking the title of your required article. To view other lists of articles in the same category "Contraception (Birth Control) and Family Planning", please visit "Category Lists Homepage" or select a list from the following dropdown list of article titles.

 

List 84: Articles 41501-42000 (500 Articles)

To view other lists in the same category, please VISIT LISTS HOME PAGE or select a list from the above dropdown list of article titles
  1. An experimental study of the effect of group meetings on the acceptance of family planning in Taiwan.
  2. Extension approach to family planning.
  3. Extra-uterine pregnancy occurring in a woman wearing an intra-uterine contraceptive device. [Grossesse extra-uterine survenant chez une femme portant un appareil anticonceptionnel intra-uterin.]
  4. Factors affecting family planning activities.
  5. Factors affecting the acceptability of oral contraception.
  6. Family planning and fecundity.
  7. Family planning and public health in Georgia: an enlarged commitment.
  8. Family planning and the population problems of Hong Kong.
  9. A family planning hypothesis: some empirical evidence from Puerto Rico.
  10. Family planning in Chile.
  11. Family planning in cross-national perspective: an overview.
  12. Family planning in England and India.
  13. Family planning in India.
  14. Family planning in India.
  15. Family planning in Kenya.
  16. Family planning in Mauritius.
  17. Family planning in the context of community health services in rural Ceylon.
  18. Family planning news and views.
  19. Family Planning Program: the Moroccan experience. [Programme de la planifaction familiale, experience marocaine.]
  20. Family planning programme in India.
  21. Family planning programme.
  22. Family planning programs throughout the world: the Tunisian Program. [Programme du planning familial dans le monde. Programme Tunisien.]
  23. Family planning service (guidelines for industries)
  24. Family planning trends: the Hungarian experience.
  25. A family planning unit for your hospital?
  26. Family planning, public policy and intervention strategy.
  27. Family planning: a challenge to health workers of every nation.
  28. Fertility and family planning in rural Korea.
  29. Fertility, family planning and the social organization of family life: some methodological issues.
  30. First Seminar-Workshop for Family Life Leaders. Theme: "Population Problems and Family Planning". November 18-22, 1967, University of the Philippines, Diliman, Quezon City.
  31. Foreign aid for family planning.
  32. Freedom from fear. (Oral contraceptives)
  33. Future trends. (Contraception)
  34. General survey. (Health and family planning)
  35. Haemoglobin concentration and other values in women using an intrauterine device or taking corticosteroid contraceptive pills.
  36. Health education in family planning programmes.
  37. Hepatic effects of oral contraceptives.
  38. Histological picture of the endometrium in intrauterine contraception. [Histologicky obraz endometria u intrauterinni antikoncepce.]
  39. The history of contraceptives.
  40. Homonymous hemianopia after oral contraceptives.
  41. Hormonal treatment with oral contraceptives.
  42. Hormone balance of oral contraceptives.
  43. Human growth hormone levels in normal subjects receiving an oral contraceptive.
  44. The Hungarian fertility and family planning study of 1965-66.
  45. Hypotheses for family planning among the urban disadvantaged: United States.
  46. Immediate postpartum insertion of an intrauterine contraceptive device.
  47. The impact of family planning on fertility in a rural area of East Pakistan.
  48. The impact of family planning programmes on incidence of abortion.
  49. Impact of family planning programmes on the birth rate.
  50. Impact of new family planning approaches on rural maternal and child health coverage in developing countries: India's example.
  51. The impact of the family planning movement on the Indian population. [Abstract]
  52. Important reduction in oral contraceptive dosage: new Norinyl-1.
  53. India: a study in family planning communication, Meerut District.
  54. India: evaluation of a publicity program of family planning.
  55. Influence of pregnancy and oral contraception on the incidence of strokes in women of childbearing age.
  56. Information and educational factors in the domain of family planning. [Facteur d'information et d'education dans le domaine du planning familial.]
  57. Inhibition of progesterone biosynthesis by 10beta-hydroperoxy-17alpha-ethynyl-4-estren 17beta-ol-3-one (Sch 10015), a postovulatory contraceptive. (Abstract only)
  58. Integration of maternity care and family planning services.
  59. Inter-generational mobility and family planning in urban Brazil. [Abstract]
  60. International experience with contraceptive methods. [Experiences internationales des methodes anticonceptionelles.]
  61. International Planned Parenthood Federation: Survey of member organizations.
  62. International postpartum family planning program (Report on the first year.)
  63. International postpartum family planning program: report on the first year.
  64. Intra-uterine contraception: recommended procedures for data analysis.
  65. Intra-uterine contraception: recommended procedures for data analysis.
  66. Intra-uterine contraception: research report.
  67. Intra-uterine contraception: research report.
  68. Intra-uterine contraceptive device.
  69. Intrauterine contraception and the terminal endometrial circulation. [Intrauterine Antikonzeption und terminale Strombahn im Endometrium.]
  70. The intrauterine contraceptive device.
  71. Intrauterine contraceptive devices: a comparison between their use in indigent and private patients.
  72. Intrauterine devices: contraceptive or abortifacients?
  73. Intrauterine pH of women using stainless steel contraceptive device.
  74. The introduction of contraception in an urban public hospital.
  75. Iran: report on population growth and family planning.
  76. Japan's experience in family planning: past and present.
  77. Jaundice and oral contraceptive drugs.
  78. Jaundice and Oral Contraceptives.
  79. Laparotomy observations during oral contraception.
  80. Latin America newspaper coverage of population and family planning.
  81. Legal aspects of sterilization and contraception.
  82. The levels of 17-hydroxycorticosteroids in the plasma of users of oral contraceptives.
  83. A light and electron microscope study of cells in contact with intrauterine contraceptive devices.
  84. Liver ultrastructure and function in icteric and non-icteric women using oral contraceptive agents.
  85. Long and short-term side-effects of oral contraceptives.
  86. A long-acting progestational agent as a contraceptive method.
  87. Long-term effects of oral contraception.
  88. Long-term evaluation of two oral contraceptives.
  89. Male motivation to family planning.
  90. Margaret Sanger and the modern contraceptive techniques.
  91. Measurement of impact of family planning programme on fertility in Pakistan.
  92. Mechanism of action of intra-uterine contraceptive devices.
  93. The mechanisms of action of contraceptive steroids. [Verkningsmechanismer vid hormonell kontraception.]
  94. Medical aspects of fertility regulation and contraception.
  95. Medical contraindications to oral contraceptives.
  96. Melasma and other skin manifestations of oral contraceptives.
  97. Melasma induced by oral contraceptive drugs.
  98. Midwife as a local functionary and her role in family planning: some research findings. [Abstract]
  99. Migraine and oral contraceptives. (Letter to the editor)
  100. Mood and behavioral changes associated with the use of the oral contraceptive agents.
  101. The morbidity and mortality of oral contraceptives.
  102. The multiple decrement life table as an approach to the measurement of use effectiveness and demographic effectiveness of contraception.
  103. Muslim attitudes toward family planning.
  104. National intra-uterine contraception report, 1967.
  105. The need for family planning as a student health service.
  106. Need for national family planning drive.
  107. Neurological aspects of contraceptives. [Aspectos neurologicos de los anticonceptivos.]
  108. Neurological disorders associated with oral contraceptives.
  109. New facts on long-term application of hormonal contraceptives.
  110. A new intrauterine contraceptive device.
  111. A new low dosage oral contraceptive: 1.0 mg. norethindrone.
  112. Normal vaginal microbiology of women of childbearing age in relation to the use of oral contraceptives and vaginal tampons.
  113. Norquen, a low dose oral contraceptive.
  114. Observations after four years of experience with the intrauterine plastic loop at the Buffalo Planned Parenthood Center.
  115. The occurrence of breakthrough bleeding with the use of oral contraceptives.
  116. On technical assistance in the field of family planning. [Abstract]
  117. On the reliability of the temperature method in contraception. [Uber die Zuverlassigkeit der temperaturmethode zur Empfangnisverhutung.]
  118. One-pill-a-month contraceptive.
  119. Opinion survey on family planning in Morocco. [Enquete d'opinion sur le planning familial au Maroc.]
  120. Oral contraception and thrombo-embolic disease.
  121. Oral contraception in epileptics.
  122. Oral contraception.
  123. The oral contraceptive: an appraisal and review.
  124. Oral contraceptives and dental care.
  125. Oral contraceptives and depression.
  126. Oral contraceptives and intravenous glucose tolerance. Data noted early in treatment.
  127. Oral contraceptives and intravenous glucose tolerance: II. long-term effect.
  128. Oral contraceptives and neurological illness.
  129. Oral contraceptives and plasma amino-acids.
  130. Oral contraceptives and thrombo-embolic disease.
  131. Oral contraceptives and thrombo-embolism.
  132. Oral contraceptives and thromboembolic disease.
  133. Oral contraceptives and thromboembolism.
  134. Oral contraceptives and thromboembolism.
  135. Oral contraceptives and thromboembolism.
  136. Oral contraceptives and thromboembolism.
  137. Oral contraceptives and varicose veins.
  138. Oral contraceptives renin, aldosterone, and high blood pressure.
  139. Oral contraceptives, thrombosis, and sickle cell hemoglobinopathies.
  140. Oral contraceptives.
  141. Oral contraceptives.
  142. Oral contraceptives.
  143. Oral contraceptives.
  144. Oral contraceptives: renin, aldosterone, and higher blood pressure.
  145. Oral contraceptives: the first decade.
  146. Organizations in charge of promoting birth control movements.
  147. Our experience with the use of vaginal contraceptives -1958-1967. [NASA iskustva sa primenom vaginalnih kontraceptivnih sredstava -1958-1967.]
  148. Ovarian tumours and other ovarian changes induced in mice by two 19-nor-contraceptives.
  149. Pathological changes induced in the uterus of mice with the prolonged administration of progesterone and 19-nor-contraceptives.
  150. Patient acceptance of oral contraceptives.
  151. The peaceful revolution: birth control and the changing status of women. (Papers presented at Planned Parenthood's Fiftieth Anniversary Conference, New York, October 1966))
  152. Pelvic actinomycosis in the presence of an endocervical contraceptive device. Report of a case.
  153. Pelvic inflammation and the intrauterine contraceptive device.
  154. Physiological mechanisms responsible for the effectiveness of oral contraceptives.
  155. (A pill-a-day birth control.)
  156. A pilot programme for family planning in Thailand: review of one year of operation in Potharam, 1964-1965.
  157. A pilot study of the success or failure of low income Negro families in the use of birth control.
  158. The place of family planning in community integration and development.
  159. The place of local and vaginal methods of contraception.
  160. Planned parenthood and sex attitudes.
  161. Planned parenthood--a duty and a human right.
  162. The planning of family size in the different social classes according to the results of investigations in Schleswig-Holstein, Federal Republic of Germany. [Abstract]
  163. The polls: More on the population explosion and birth control.
  164. Population policy and family planning in Iran.
  165. A possible role for granulocytes in the action of intrauterine contraceptive devices.
  166. Post-coital oral contraception.
  167. Postcoital contraception.
  168. The safety of oral contraceptives--a case study in medical administration.
  169. Safety of oral contraceptives.
  170. The safety of oral contraceptives.
  171. In search of an ideal contraceptive.
  172. Sedimentation rate in the normal menstrual cycle or with oral contraceptives.
  173. Selected questionnaires on knowledge, attitudes, and practice of family planning, Vol. I.
  174. Selected questionnaires on knowledge, attitudes, and practice of family planning, Vol. II.
  175. Sequential oral contraceptive treatment and intravenous glucose tolerance. [Letter]
  176. Serum protein and cholinesterase changes in association with contraceptive pills.
  177. Should genital candidosis be considered a side-effect of oral contraception.
  178. Should nullipara and infertility patients be given oral contraceptives?
  179. Side effects of an oral contraceptive with particular attention to mental symptoms and sexual adaptation.
  180. Side effects of contraceptive medication in a university-associated population.
  181. Side-effects of oral contraceptives.
  182. Social and economic correlates of fertility and family planning.
  183. Sociologic study of Family planning in Morocco. [Etude sociologique sur le planning familial au Maroc.]
  184. Some aspects of fertility and family planning in Seoul City, Korea.
  185. Some aspects of studies with low dosage ethynodiol diacetate administration in combined or sequential tablets for long term oral contraception in Indian women.
  186. Some considerations in developing family planning services.
  187. Some socio-demographic characteristics of women seeking contraceptive advice in one of the southern clinics of Tehran.
  188. Some thoughts on the side effects of oral contraceptives.
  189. Statistical data on the problem of birth control and family planning. [Statistische Unterlagen zum Problem der Geburtenkontrolle und der Famili enplanung.]
  190. Sterility Following Oral Contraceptives.
  191. Strokes in young women using oral contraceptives.
  192. Structures of contraceptive steroids. [Les structures contraceptives.]
  193. Studies of the mode of action of intrauterine contraceptive device.
  194. A study in family planning communication: Meerut district.
  195. A study of knowledge, attitude and practice of family planning in West Pakistan.
  196. Summary of family planning in Islamic legislation. [Apercu sur la planification familiale dans la legislation islamique.]
  197. Survey and status of IPPF family planning programmes: Africa report.
  198. Survey and status of IPPF family planning programmes: Europe and Near East Region report.
  199. Survey and status of IPPF family planning programmes: Indian Ocean Region report.
  200. Survey and status of IPPF family planning programmes: South East Asia and Oceania Region report.
  201. Survey and status of IPPF family planning programmes: Western Hemisphere Region report.
  202. Survey and status of IPPF family planning programmes: Western Pacific Region report.
  203. A survey of recent research on the mode of action of intra-uterine contraceptive devices.
  204. Sympto thermic family planning.
  205. Syndrome of anovulation following the oral contraceptives.
  206. A synopsis of the Scientific Conference on New, Low Dosage Oral Contraception, Palo Alto, California, July 15, 1965.
  207. Taiwan's family planning in charts: second edition.
  208. Temporary sterilization of the male by intravasal contraceptive device (IVCD): a preliminary communication.
  209. Thromboembolic disease and oral contraceptives.
  210. Thyroid hyperplasia due to oral contraceptives.
  211. Thyroid status in pregnancy and in women taking oral contraceptives.
  212. Towards effective family planning.
  213. Training in family planning.
  214. Understanding conception and contraception.
  215. The United States: a strategy for implementing family planning services.
  216. The United States: a strategy for implementing family planning services.
  217. Urinary coproporphyrin excretion and hepatic function in women taking oral contraceptives.
  218. Urinary steroid and gonadotropin excretion in women following long-term use of oral contraceptives.
  219. Use of intrauterine contraceptive devices in the postpartum period.
  220. The use of oral contraceptives in the presence of associated diseases.
  221. Use of oral contraceptives: with special reference to developing countries.
  222. Uterine perforation with intrauterine contraceptive devices. Review of the literature and cases reported to the National Committee on Maternal Health.
  223. Varicose veins, oral contraceptives, and thromboembolism.
  224. Vascular bruits and oral contraceptives.
  225. Vasectomy for contraception.

     

  226. Where Oregon is today in family planning.
  227. Which contraceptive pill?
  228. WMA resolution on family planning.
  229. Young woman, oral contraceptive, thrombosis: case report presented at the Clinical Pathologic Conference No. 482.
  230. The AID computer programme, used to predict adoption of family planning in Koyang.
  231. Oral contraceptives and thyroid function tests.
  232. Sequential mestranol-chlormadinone acetate as an oral contraceptive.
  233. Sequential oral contraception using DMPA.
  234. Perforation of the postpartum uterus with an intrauterine contraceptive device.
  235. Personnel problems in family planning programs. 25.
  236. Pituitary-adrenal function in oral contraception.
  237. The place of conventional methods in family planning programs.
  238. Planning of clinical trials with oral contraceptives.
  239. Plasma insulin and blood glucose levels in patients taking oral contraceptives.
  240. Post-coital oral contraception.
  241. Practical aspects of family planning in Kampala.
  242. Predicting the adoption of family planning.
  243. Preliminary clinical study of Wy 3707 with ethinyl estradiol as an oral contraceptive.
  244. Probable mode of action of oral contraceptives.
  245. Problems of administration: family planning programme in Pakistan.
  246. Progress of the family planning action program in Taiwan: use of IUDs and their problems.
  247. Promotion and progress of family planning action program in Taiwan: an example of non-governmental approach.
  248. A prospective study towards a national family planning program.
  249. Proximity and other geographical factors in family planning clinic utilization in Pakistan.
  250. The psychological effects of birth control. [Reactions psycho-affectives a la contraception.]
  251. Puerto Rico (Family planning)
  252. The rationale of the prohibition (against contraception)
  253. Readings on emergency contraception.
  254. Recent developments in family planning that promise hope in coping with the population crisis in Asia and throughout the world.
  255. Recent trends in family planning research in India.
  256. Records and record-keeping in family planning programs.
  257. The religious factor in differential fertility and family planning attributes in metropolitan New Orleans.
  258. Report about the survey of 3300 clients visiting family planning clinic at Hyderabad.
  259. Report on the oral contraceptives.
  260. A review of literature on intrauterine contraceptive devices in Japan.
  261. Review of the procedures and reports of the pharmaceutical companies concerned with the manufacture and sale of the oral contraceptives.
  262. Role of Bharat Sevak Samaj in the field of public health, medical care and family planning.
  263. The role of civic and volunteer workers in family planning (Philippines)
  264. The role of teachers and health educators in family planning.
  265. The role of the dose of progestogen, the role of the dose of oestrogen, and the dosage scheme on the mode of action, effectiveness and side-effects of oral contraceptives.
  266. Abortion and bacterial shock induced with an intrauterine contraceptive device: report of a case.
  267. Acceptability of oral contraceptives.
  268. Acceptance (oral contraceptives)
  269. Acceptance of intra-uterine contraception by postpartum women.
  270. Administrative aspects of family planning programmes in Asia: report on a workshop.
  271. Administrative aspects of family planning programmes.
  272. Administrative aspects of family planning programmes: report of a working group.
  273. Africa (and family planning)
  274. Aims and achievements of the family planning programme.
  275. Alteration of cephalin-cholesterol flocculation in patients taking oral contraceptive agents [letter]
  276. Amenorrhoea after treatment with oral contraceptives.
  277. Application of life table techniques to measurement of contraceptive effectiveness.
  278. An appraisal of certain problems involved in the use of steroid compounds for contraception.
  279. An appraisal of the clinical effect of three different oral contraceptive agents and their influence on transaminase activity.
  280. Aspects of a new oral contraceptive, Ovulen.
  281. Attitudes of individual California physicians and policies of state medical societies on vasectomy for birth control.
  282. Attitudes of medical auxiliary personnel in Kenya toward family planning.
  283. Breast problems and oral contraceptives: a clinical note.
  284. Candida albicans and the contraceptive pill.
  285. Ceylon. (family planning)
  286. Chile (family planning)
  287. Chloasma and oral contraceptives.
  288. Cholestatic jaundice caused by contraceptive steroids and its relation to intrahepatic cholestatic jaundice of pregnancy.
  289. Clinical acceptability of contraceptive vaginal foam tablets.
  290. Clinical comparison of clients who attended for chemical contraception.
  291. Clinical experience with oral contraceptives in England.
  292. Clinical experience with the Margulies intrauterine contraceptive device.
  293. Clinical results of treatment with megestrol acetate in menstrual disorders and contraception.
  294. Clinical trial of a combination of lynestrenol and mestranol (Lyndiol) as an oral contraceptive agent.
  295. Clinical trials (oral contraceptives)
  296. Clotting factors during oral contraception: further report.
  297. Coeds and contraceptive information.
  298. Communication about birth control: an exploratory study of freshman girls' information and attitudes.
  299. Community approaches as process of changing family planning attitudes.
  300. Community power structure in the family planning program.
  301. A comparative evaluation of intrauterine contraceptive devices.
  302. Comparative study of intrauterine contraceptive devices: spiral loop, and ring.
  303. A comparison of husbands' and wives' attitudes toward family planning.
  304. The Consumers Union report on family planning, 2nd edition.
  305. Contact lenses and oral contraceptives.
  306. Contact lenses and oral contraceptives.
  307. Contact lenses and oral contraceptives.
  308. Contraception and lactation.
  309. Contraception in the Roman Empire.
  310. Contraception with intrauterine devices: 1959-1966.
  311. Contraception, diagnosis, and therapy with ovulation inhibitors. [Prophylaxe, Diagnostik und Therapie mit Ovulationshemmern.]
  312. Contraception: a history of its treatment by the Catholic theologians and canonists.
  313. Contraceptive devices and endometrium.
  314. Contraceptive information and sexual morality.
  315. Contraceptive methods: use, safety, and effectiveness.
  316. Contraceptive techniques: means and dissemination in the High Middle Ages.
  317. Contraceptive testing in India.
  318. Control of contraception by hormonal steroids.
  319. Cytology and the contraceptive pill.
  320. The Danfa Family Planning Program in Rural Ghana.
  321. Demographic implications of the first six years of family planning in Karachi, 1958-64.
  322. Description of the established methods of birth control. [Description sommaire des principales methodes bien etablies de contraception.]
  323. Detailed investigations in Egypt with oral contraceptives.
  324. Determination of ovulation time and the rhythm method of contraception.
  325. Development of community health service from family planning clinic service. (Abstract only)
  326. The development of family planning in Egypt: data from Cairo family planning centers.
  327. Distribution of contraceptive supplies through commercial channels.
  328. The effect of an intrauterine contraceptive device on the weight of the rat uterus.
  329. Effect of an intrauterine contraceptive device upon cervical and endometrial exfoliative cytology.
  330. Effect of intrauterine contraceptive devices on the endometrium.
  331. The effect of oral contraceptives on gonadotrophin excretion.
  332. Effect of oral contraceptives on lactation.
  333. The effect of oral contraceptives on migraine.
  334. The effect of oral contraceptives on the liver.
  335. The effect of oral contraceptives on the ovary.
  336. Effectiveness of a sequential oral contraceptive tablet.
  337. Effects of some steroids in oral contraceptives on the cleavage of rabbit eggs in vitro.
  338. The electroencephalogram and personality of women with headaches on oral contraceptives.
  339. Electroencephalographic changes during long term treatment with oral contraceptives.
  340. Endometrial changes induced by the administration of an oral contraceptive, Norethindrone (S-3800B)
  341. Endometrial effects of an intrauterine contraceptive device.
  342. Estrogen-progestogen combination for contraception.
  343. Evaluation procedures for a family planning program.
  344. Family growth and family planning in a rural district of Thailand.
  345. Family planning advice.
  346. Family planning and mental health: summary of discussions held at National Institutes of Health, January 13, 1966.
  347. Family planning and the school curriculum.
  348. Family planning around the world.
  349. Family planning enquiry in Dharwar Taluka Mysore State: a survey conducted in Dharwar town and twenty villages of Dharwar Tuluka.
  350. Family planning enquiry in rural Shimoga (Mysore State): a survey conducted in a region currently experiencing a high rate of growth in population.
  351. Family planning in Egypt: an introduction.
  352. Family planning in Singapore.
  353. Family planning in the Fourth Plan.
  354. Family planning in the Pacific region.
  355. Family planning is a missionary activity.
  356. A family planning program related to maternity service.
  357. The family planning programme and the role of voluntary organisations.
  358. Family planning programme in Madhya Pradesh.
  359. Family planning programmes and action in Western Europe.
  360. Family planning programs today: major themes of the conference.
  361. Family planning research: an outline of the field.
  362. Family planning will help to improve production.
  363. Family planning.
  364. Family planning.
  365. Family planning: a study of the motivation of patients who seek birth-control services.
  366. Family-planning advice after abortion.
  367. FDA report on oral contraceptives.
  368. Female contraceptive devices (vaginal diaphragms and cervical caps) [Preservatifs feminins diaphragmes et capes.]
  369. Fertility and family planning in Japan.
  370. Four years field study with oral contraception in Egypt.
  371. Galactorrhea after contraceptive hormones.
  372. Galactorrhea subsequent to contraceptive hormones.
  373. Government birth control: reply to Mr. Sirilla, S.J.
  374. Government policy and family planning (U.S.)
  375. The history and future of birth control.
  376. Hong Kong (Family planning programs)
  377. Hypertension associated with oral contraceptives.

     

  378. Hypertension associated with oral contraceptives.
  379. The impact of birth control programs on fertility.
  380. The impact of family planning programmes on incidence of abortion.
  381. Implications of the conference (On family planning programs)
  382. Importance of family planning and the role of voluntary organisation.
  383. Incidence of moniliasis with combined and sequential oral contraceptives.
  384. Increased factor VIII levels in suspected carriers of hemophilia A taking contraceptives by mouth.
  385. India: the use of community leaders to promote family planning.
  386. Industry and trade have a vital role (Family planning)
  387. The initiation of the Family Planning Association in Jinja, Uganda.
  388. International postpartum family planning program: report on an action-research demonstration study.
  389. Intra uterine contraceptive device in family planning.
  390. The intra-uterine contraception follow-up study. (Abstract only)
  391. Intra-uterine contraceptive devices by members of the Port-of-Spain F.P. Clinic.
  392. Intra-uterine contraceptives (intra-uterine contraceptives) [Contraception intra-uterine dispositifs intra-uterins, I.U.D.]
  393. Intrauterine contraception.
  394. Intrauterine contraceptive devices (IUD)
  395. Intrauterine contraceptive devices in private practice: a clinical study.
  396. Introduction ( and report on oral contraceptives)
  397. Introduction to the symposium. (Oral contraceptives)
  398. IPPF world survey: (1) factors affecting the work of family planning associations.
  399. Japan (Family Planning)
  400. Jaundice and oral contraceptive drugs.
  401. Latin America (family planning)
  402. Law No. 557 on Family Planning, of 1 January 1965, Section 1.
  403. Lessons learned from family planning studies in Taiwan and Korea.
  404. Liver damage from oral contraceptives.
  405. Long-acting contraceptives.
  406. Long-term study of oral contraception with nonrethindrone 2 mg. and mestranol 0.1/mg.
  407. Low dosage progestin/oestrogen combination in oral contraception.
  408. Low-dosage oral ethynodiol diacetate tablets for long-term contraception in Indian women.
  409. Lyndiol: evaluation of safety and efficacy as an oral contraceptive.
  410. Making better and safer oral contraceptives.
  411. Male contraceptives (condoms) [Preservatifs masculins--condoms.]
  412. Marginal-dose contraception in the puerperium.
  413. Mass use of intra-uterine contraceptive devices in Korea.
  414. Mechanism of action of oral contraception.
  415. The medical aspects of family planning.
  416. Methods and effectiveness of contraception.
  417. Methods of administration. (Oral contraceptives.)
  418. Moral aspects of family planning in contemporary Christian society (Philippines)
  419. The national family planning program as a strategic platform for the improvement of maternal and child health in Korea.
  420. National intra-uterine contraception report.
  421. Neurological syndromes occurring in patients receiving synthetic steroids (oral contraceptives)
  422. New facts on short- and long-term administration of hormonal contraceptives.
  423. A new progestogen-estrogen combination for gynecologic therapy and contraception.
  424. A new sequential oral contraceptive evaluated.
  425. A new synthetic low dose progestagen-estrogen compound for oral contraception. (Abstract only)
  426. A note on college marriage course student knowledge of contraception.
  427. The nurse-midwife in a family planning clinic.
  428. An observation on the contraceptive mechanism of intrauterine contraceptive devices.
  429. On population control and family planning (Philippines)
  430. Ophthalmologic findings in patients using oral contraception.
  431. Oral contraception - U.K. experience.
  432. Oral contraception by the sequential approach.
  433. Oral contraception.
  434. Oral contraceptive medication: a prolonged experience.
  435. Oral contraceptive medications and thrombophlebitis: thrombophlebitis in women between ages of ten and fifty-five.
  436. Oral contraceptive program synchronized with moon phase.
  437. Oral contraceptive trial in the Fiji Islands.
  438. Oral contraceptives (estrogen-progesterone pills) [Contraception oral par comprimes oestroprogestatifs.]
  439. Oral contraceptives and carbohydrate metabolism.
  440. The oral contraceptives and infertility.
  441. Oral contraceptives and the liver.
  442. Oral contraceptives in the spotlight. [Prevensjonstablettene i sokelyset.]
  443. Oral contraceptives, thrombosis, and clinical factors affecting veins. (Letter to the editor)
  444. Oral contraceptives.
  445. Oral contraceptives.
  446. Oral contraceptives.
  447. Oral contraceptives.
  448. Oral contraceptives.
  449. Oral contraceptives: safety factors in prolonged use of progestin-estrogen combinations, part 2.
  450. Other methods of contraception. [Autres methodes de control biologique de la conception.]
  451. Ovulen as an oral contraceptive.
  452. Pakistan. (Family planning)
  453. Panel discussion. (Contraceptive Agents)
  454. The role of the Red Cross in the field of public health, medical care and family planning.
  455. Role of vasectomy in family planning.
  456. Rural family planning: a search for an approach (Philippines)
  457. The safety of oral contraceptives.
  458. Sanctions. (Contraception in the Middle Ages.)
  459. Sequential mestranol-norethindrone for oral contraception.
  460. Serum lipids and lipoproteins during long-term administration of an oral contraceptive.
  461. Seven cases of jaundice in women taking an oral contraceptive, Anovlar.
  462. Side effects of oral contraceptives.
  463. Side effects of oral contraceptives.
  464. Side effects of oral contraceptives: An investigation of 4 gestagens using a double blind crossover technique.
  465. Side effects: combination treatment. (Oral contraceptives)
  466. Side-effects and possible complications of oral contraceptive drugs.
  467. The size and shape of the uterine cavity determined by hysterography with an intrauterine contraceptive device as a marker.
  468. Social aspects of family planning in Denmark.
  469. Social aspects of family planning in Finland.
  470. Social aspects of family planning in Turkey.
  471. The socialist countries of Europe (And family planning)
  472. Socio-economic study of women attending an urban clinic and their attitude towards oral contraceptives.
  473. Sociocultural research in family planning in the United States: review and prospects.
  474. Some aspects of studies with oral contraceptives in Indian women.
  475. Some effects of oral contraceptives on carbohydrate metabolism.
  476. Specification for diaphragms for contraceptive use. B.S. 4028: 1966.
  477. The spread of birth control: the responses of the bishops and the Pope.
  478. Statistical evaluation of the effect of hormonal contraceptives on the cytologic smear pattern.
  479. Steroid oral contraceptives.
  480. Steroidal oral contraceptive agents.
  481. Studies of fertility and family planning in the Philippines.
  482. Studies on the intrauterine contraceptive device.
  483. Studies relevant to family planning. [Moderator's statement]
  484. Studies relevant to family planning. [Rapporteur's statement]
  485. A summary of contraceptive methods: how they work, effectiveness, accept ability.
  486. Summary of the discussions held at a conference of the behavioral sciences and family planning programs.
  487. Symposium on contraception: chemical agents.
  488. Systemic lupus erythematosus exacerbated by oral contraceptives.
  489. Take-off in family planning.
  490. Ten weeks' intensive campaign to promote family planning in Ambala district and Punjab state.
  491. Thromboembolism and oral contraceptives: post or propter?
  492. Thrombosis of the hepatic vein: "The Budd-Chiari Syndrome"--A possible link between oral contraceptives and thrombosis formation.
  493. Tunisia. (family planning)
  494. Turkey (family planning)
  495. U.S. expanding aid to birth control.
  496. The United States medical profession and family planning.
  497. Ureteral dilatation following use of oral contraceptives.
  498. Use of oral contraception in the United States, 1965.
  499. Uterine histo-pathology in patients fitted with plastic intrauterine contraceptive devices.
  500. Vaginal chemical contraceptives (spermicides) [Contraception chimique locale spermicides.]

To view other lists of the current category of articles, please visit "Category Lists Homepage"


Web PubHealth.info

© Copyrights PubHealth.info®, an information portal on public health. All rights reserved.

This page is optimized to be viewed by Java script enabled Microsoft® Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels.